-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Xenetic Biosciences, Inc. quarterly/annual Revenues history and growth rate from 2012 to 2024.
- Xenetic Biosciences, Inc. Revenues for the quarter ending December 31, 2024 was $649K, a 3.44% decline year-over-year.
- Xenetic Biosciences, Inc. Revenues for the twelve months ending December 31, 2024 was $2.5M, a 1.56% decline year-over-year.
- Xenetic Biosciences, Inc. annual Revenues for 2024 was $2.5M, a 1.56% decline from 2023.
- Xenetic Biosciences, Inc. annual Revenues for 2023 was $2.54M, a 48.8% increase from 2022.
- Xenetic Biosciences, Inc. annual Revenues for 2022 was $1.71M, a 47.1% increase from 2021.